Johnson & Johnson Recalls Tylenol Citing Musty Odor for Third Time in Year

Johnson & Johnson’s McNeil Consumer Healthcare unit said it is recalling one product lot of Tylenol 8-hour caplets containing 127,728 bottles, following complaints from consumers of a musty or moldy odor.

The recall is the third in the past year linked to odors affecting medications made by the New Brunswick, New Jersey- based company. The odor is thought to be tied to a chemical called 2,4,6-tribromoanisole, said Marc Boston, a spokesman for McNeil. The chemical is applied to wooden pallets used to store packing materials, J&J has said.

J&J received a warning letter in January from the Food and Drug Administration saying the company had waited more than a year to notify regulators after receiving complaints early in 2008 about odors in Tylenol Arthritis Pain Caplets. The company recalled some lots of the medicine in December 2009 and, a month later, announced that a variety of over-the-counter products would be recalled because of similar odor complaints. Lawmakers and the FDA also are investigating J&J in connection with a separate April recall of more than 40 types of children’s medicines.

“We believe it’s from packing components and we’re continuing to investigate,” Boston said in a telephone interview about today’s Tylenol recall.

J&J gained 29 cents, or less than 1 percent, to $63.86 at 4 p.m. in New York Stock Exchange composite trading. The company’s shares increased 5.6 percent in the past 12 months.

To contact the reporter on this story: Rob Waters in San Francisco at rwaters5@bloomberg.net.

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.